HIV i-Base news story
CROI 2026 included an oral plenary talk on the use of GLP-1 receptor agonists in people living with HIV, plus an additional oral presentation and seven posters.
These covered the short-term impact of GLP-1s in a real-world setting, potential benefits on reducing smoking, cardiovascular risk, depression, and liver fibrosis, with an oral abstract on the potential to perhaps reverse the gut damage that occurs in very early HIV infection and that persists despite effective ART.
Read the full news story here.
View all HIV i-Base reports from CROI 2026
Source : HIV i-Base
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.